GGrantIndex
Sort

39,280 grants matching leukemia

CLINICAL PHARMACOKINETICS AND SAFETY TRIALS IN DOWN SYNDROME

$2,298,706
Mara Becker · Duke University · N01 · FY2020 · HD

SPORE: Targeted Therapies for Glioma

$2,298,683
Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2020 · CA

THERAPY OF AML

$2,297,886
University Of Texas Md Anderson Can Ctr · P01 · FY2003 · CA

Experimental Therapeutics of Leukemia

$2,295,172
John C Byrd · Ohio State University · P50 · FY2012 · CA

Harnessing Single Cell Technology to Define Self-Renewal in Normal and Malignant Stem Cells

$2,295,000
Jessica S. Blackburn · University Of Kentucky · DP2 · FY2017 · CA

The Immunobiology of Marrow Allografts for Leukemia

$2,294,717
Sloan-Kettering Institute For Cancer Res · P01 · FY2003 · CA

Adult Leukemia Research Center

$2,292,615
Geoffrey Roger Hill · Fred Hutchinson Cancer Center · P01 · FY2021 · CA

Cancer and Leukemia Group B CCOP Research Base

$2,286,202
Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2012 · CA

Development of New Antitumor Agents

$2,285,466
Southern Research Institute · P01 · FY2005 · CA

ECOG-ACRIN Biorepositories to Support NCTN

$2,285,075
Ignacio I. Wistuba · Ecog-Acrin Medical Research Foundation · U24 · FY2015 · CA

Genetics and Genomics of Leiomyosarcoma (LMS): Improved understanding of cancer biology and new approaches to diagnosis and treatment

$2,282,833
Scott Michael Schuetze · University Of Michigan At Ann Arbor · P50 · FY2022 · CA

Repository Services for epidemiology studies

$2,282,355
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2015 · CA

COG NCTN Year 12 BIQSFP Progress Report

$2,276,944
Douglas S. Hawkins · Public Health Institute · U10 · FY2025 · CA

SPORE in Multiple Myeloma

$2,276,698
Kenneth C Anderson · Dana-Farber Cancer Inst · P50 · FY2019 · CA

Genetics and Genomics of Leiomyosarcoma (LMS): Improved understanding of cancer biology and new approaches to diagnosis and treatment

$2,274,206
Scott Michael Schuetze · University Of Michigan At Ann Arbor · P50 · FY2023 · CA

DNA Methylation & Chromatin Modifications: Mechanisms & Applications in Cancer*

$2,271,783
Samson T Jacob · Ohio State University · P01 · FY2008 · CA

Developmental and HyperActive Ras Tumor SPORE

$2,271,783
David W. Clapp · Indiana University Indianapolis · U54 · FY2017 · CA

Immunotherapy of low grade lymphoid malignancies

$2,271,399
Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL

Bone Marrow Transplantation in Human Disease

$2,269,507
Richard J Jones · Johns Hopkins University · P01 · FY2019 · CA

ETIB Clinical Trials

$2,268,710
Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

ETIB Clinical Research Core

$2,268,710
Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2013 · CA

Genes and signals controlling mammalian hematopoiesis.

$2,266,693
Paul E Love · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD

SPORE in Lymphoma

$2,266,618
Helen E Heslop · Baylor College Of Medicine · P50 · FY2009 · CA

SPORE in Lymphoma

$2,266,618
Helen E Heslop · Baylor College Of Medicine · P50 · FY2010 · CA

SPORE in Lymphoma

$2,266,618
Helen E Heslop · Baylor College Of Medicine · P50 · FY2008 · CA